GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » EV-to-Revenue

CHE (Chemed) EV-to-Revenue : 3.23 (As of Jun. 16, 2025)


View and export this data going back to 1972. Start your Free Trial

What is Chemed EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Chemed's enterprise value is $8,034 Mil. Chemed's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $2,489 Mil. Therefore, Chemed's EV-to-Revenue for today is 3.23.

The historical rank and industry rank for Chemed's EV-to-Revenue or its related term are showing as below:

CHE' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.46   Med: 3.49   Max: 4.32
Current: 3.23

During the past 13 years, the highest EV-to-Revenue of Chemed was 4.32. The lowest was 1.46. And the median was 3.49.

CHE's EV-to-Revenue is ranked worse than
68.86% of 668 companies
in the Healthcare Providers & Services industry
Industry Median: 1.785 vs CHE: 3.23

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-16), Chemed's stock price is $551.15. Chemed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was $165.56. Therefore, Chemed's PS Ratio for today is 3.33.


Chemed EV-to-Revenue Historical Data

The historical data trend for Chemed's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed EV-to-Revenue Chart

Chemed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.06 3.82 3.64 3.83 3.16

Chemed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 3.45 3.75 3.16 3.60

Competitive Comparison of Chemed's EV-to-Revenue

For the Medical Care Facilities subindustry, Chemed's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemed's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Chemed's EV-to-Revenue falls into.


;
;

Chemed EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Chemed's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8034.216/2488.997
=3.23

Chemed's current Enterprise Value is $8,034 Mil.
Chemed's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,489 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemed  (NYSE:CHE) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Chemed's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=551.15/165.564
=3.33

Chemed's share price for today is $551.15.
Chemed's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $165.56.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemed EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Chemed's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemed Business Description

Traded in Other Exchanges
Address
255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Executives
Spencer S Lee officer: vice president 2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Kevin J Mcnamara director, officer: president & ceo 2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Brian C Judkins officer: VP and Chief Legal Officer 255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Walsh George J Iii director ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Nicholas Michael Westfall officer: Executive Vice President 8035 PEREGRINE LANE, CINCINNATI OH 45243
Andrea R Lindell director
Thomas C Hutton director, officer: vice president ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Patrick P Grace director 1100 PARK AVE, APT 15C, NEW YORK NY 10128
Michael D Witzeman officer: vice president and controller 255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
David Patrick Williams officer: Vice President & CFO
Eileen P Mccarthy director 3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Mount John Meredith Jr. director 2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders director 306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney director 101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons director 2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208